Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma

about

Minimally invasive image-guided therapies for hepatocellular carcinoma Advances and Future Directions in the Treatment of Hepatocellular Carcinoma

P2860

Q28079027-486B31E6-264D-4DD0-BBE6-491C36F4CB5A Q41531360-369704A7-55A6-4B8F-A761-D26BE58C7233

P2860

Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma

Item

http://www.wikidata.org/entity/Q37197236

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 February 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Yttrium-90 resin microspheres ...... table hepatocellular carcinoma

@en

Yttrium-90 resin microspheres ...... able hepatocellular carcinoma.

@nl

type

Item

label

Yttrium-90 resin microspheres ...... table hepatocellular carcinoma

@en

Yttrium-90 resin microspheres ...... able hepatocellular carcinoma.

@nl

prefLabel

Yttrium-90 resin microspheres ...... table hepatocellular carcinoma

@en

Yttrium-90 resin microspheres ...... able hepatocellular carcinoma.

@nl

P1476

Yttrium-90 resin microspheres ...... table hepatocellular carcinoma

@en

P2093

Ahmed O Kaseb

http://www.w3.org/2001/XMLSchema#string

Ahmed S Shalaby

http://www.w3.org/2001/XMLSchema#string

Armeen Mahvash

http://www.w3.org/2001/XMLSchema#string

Bruno C Odisio

http://www.w3.org/2001/XMLSchema#string

James C Yao

http://www.w3.org/2001/XMLSchema#string

Kanwal Pratap Raghav

http://www.w3.org/2001/XMLSchema#string

Khaled M Elsayes

http://www.w3.org/2001/XMLSchema#string

Lauren Girard

http://www.w3.org/2001/XMLSchema#string

Manal Hassan

http://www.w3.org/2001/XMLSchema#string

Michael J Wallace

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hepatocellular carcinoma: An update

Sorafenib in advanced hepatocellular carcinoma

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Hepatocellular carcinoma

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.

Sorafenib modulates the radio sensitivity of hepatocellular carcinoma cells in vitro in a schedule-dependent manner

Combined-modality treatment of solid tumors using radiotherapy and molecular targeted agents.

Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A

Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers.

Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib.

P304

1-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/JHC.S62261

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joe E. Ensor

P577

2016-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27574586

http://www.w3.org/2001/XMLSchema#string

P921

microspheres

P932

4994795

http://www.w3.org/2001/XMLSchema#string

Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma

about

P2860

P2860

Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932